Role of AXL in invasion and drug resistance of colon and breast cancer cells and its association with p53 alterations.

World J Gastroenterol · 2017 · PMC5442080 · PMID 28596680

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

AXL predisposes to emergence of invasive clones after chemotherapy AXL silencing did not show a slight trend to restore breast cancer cells sensitivity to Doxorubicin and colon cancer cell sensitivity to 5FU or irinotecan (Figure 2A and B).

also in 3,004 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.